Stocks
CME Financial Statements (CME) |
||||||||||
| CMEsmart-lab.ru | % | 2023Q3 | 2023Q4 | 2023Q4 | 2024Q1 | 2024Q1 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 01.11.2023 | 31.12.2023 | 28.02.2024 | 31.03.2024 | 01.05.2024 | 01.05.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 1 338 | 1 439 | 1 439 | 1 488 | 1 488 | 5 854 | |||
| Operating Income, bln rub | 820.2 | 863.2 | 863.2 | 959.6 | 959.6 | 3 646 | ||||
| EBITDA, bln rub | ? | -170.3 | 949.5 | 949.5 | 1 045 | 1 045 | 3 989 | |||
| Net profit, bln rub | ? | 750.2 | 804.3 | 814.6 | 844.4 | 855.2 | 3 319 | |||
| OCF, bln rub | ? | 856.7 | 172.6 | 1 044 | 892.7 | 2 110 | ||||
| CAPEX, bln rub | ? | 19.9 | 0.000 | 20.8 | 19.8 | 40.6 | ||||
| FCF, bln rub | ? | 836.8 | 172.6 | 1 024 | 872.9 | 2 069 | ||||
| Dividend payout, bln rub | 400.0 | 0.000 | 400.1 | 2 328 | 2 729 | |||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 53.3% | 0.00% | 49.1% | 0.00% | 272.3% | 82.2% | ||||
| OPEX, bln rub | 312.1 | 314.8 | 314.8 | 262.6 | 262.6 | 1 155 | ||||
| Cost of production, bln rub | 205.5 | 261.3 | 261.3 | 265.7 | 265.7 | 1 054 | ||||
| R&D, bln rub | 55.6 | 0.000 | 58.5 | 0.000 | 59.4 | 117.9 | ||||
| Interest expenses, bln rub | 39.6 | 39.7 | 39.7 | 39.9 | 39.9 | 159.2 | ||||
| Assets, bln rub | 125 598 | 129 706 | 129 841 | 132 054 | 132 054 | 132 054 | ||||
| Net Assets, bln rub | ? | 28 152 | 26 738 | 26 738 | 27 154 | 27 154 | 27 154 | |||
| Debt, bln rub | 3 425 | 3 425 | 3 884 | 3 426 | 3 426 | 3 426 | ||||
| Cash, bln rub | 2 404 | 3 029 | 3 029 | 1 563 | 1 563 | 1 563 | ||||
| Net debt, bln rub | 1 020 | 396.5 | 855.0 | 1 863 | 1 863 | 1 863 | ||||
| Ordinary share price, rub | 200.2 | 210.6 | 210.6 | 215.3 | 215.3 | 212.5 | ||||
| Number of ordinary shares, mln | 359.0 | 359.7 | 359.2 | 359.3 | 359.3 | 359.3 | ||||
| Market cap, bln rub | 71 883 | 75 751 | 75 647 | 77 345 | 77 345 | 76 353 | ||||
| EV, bln rub | ? | 72 903 | 76 148 | 76 502 | 79 208 | 79 208 | 78 216 | |||
| Book value, bln rub | -2 597 | 16 243 | -3 983 | 16 665 | -3 501 | -3 501 | ||||
| EPS, rub | ? | 2.09 | 2.24 | 2.27 | 2.35 | 2.38 | 9.24 | |||
| FCF/share, rub | 2.33 | 0.48 | 2.85 | 0.00 | 2.43 | 5.76 | ||||
| BV/share, rub | -7.23 | 45.2 | -11.1 | 46.4 | -9.74 | -9.74 | ||||
| EBITDA margin, % | ? | -12.7% | 66.0% | 66.0% | 70.2% | 70.2% | 68.1% | |||
| Net margin, % | ? | 56.1% | 55.9% | 56.6% | 56.8% | 57.5% | 56.7% | |||
| FCF yield, % | ? | 4.61% | 3.34% | 4.46% | 3.22% | 4.35% | 2.71% | |||
| ROE, % | ? | 10.8% | 12.0% | 12.1% | 11.7% | 11.8% | 12.2% | |||
| ROA, % | ? | 2.43% | 2.48% | 2.48% | 2.41% | 2.42% | 2.51% | |||
| P/E | ? | 23.6 | 23.6 | 23.4 | 24.3 | 24.2 | 23.0 | |||
| P/FCF | 21.7 | 30.0 | 22.4 | 31.1 | 23.0 | 36.9 | ||||
| P/S | ? | 13.4 | 13.6 | 13.6 | 13.7 | 13.7 | 13.0 | |||
| P/BV | ? | -27.7 | 4.66 | -19.0 | 4.64 | -22.1 | -21.8 | |||
| EV/EBITDA | ? | 31.0 | 29.3 | 29.5 | 29.4 | 29.4 | 19.6 | |||
| Debt/EBITDA | 0.43 | 0.15 | 0.33 | 0.69 | 0.69 | 0.47 | ||||
| R&D/CAPEX, % | 279.4% | 281.3% | 300.0% | 290.4% | ||||||
| CAPEX/Revenue, % | 1.49% | 0.00% | 1.45% | 0.00% | 1.33% | 0.69% | ||||
| CME shareholders | ||||||||||
